Literature DB >> 28074320

Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.

Nicholas Czarnek1,2, Kal Clark3, Katherine B Peters4, Maciej A Mazurowski5,3.   

Abstract

In this retrospective, IRB-exempt study, we analyzed data from 68 patients diagnosed with glioblastoma (GBM) in two institutions and investigated the relationship between tumor shape, quantified using algorithmic analysis of magnetic resonance images, and survival. Each patient's Fluid Attenuated Inversion Recovery (FLAIR) abnormality and enhancing tumor were manually delineated, and tumor shape was analyzed by automatic computer algorithms. Five features were automatically extracted from the images to quantify the extent of irregularity in tumor shape in two and three dimensions. Univariate Cox proportional hazard regression analysis was performed to determine how prognostic each feature was of survival. Kaplan Meier analysis was performed to illustrate the prognostic value of each feature. To determine whether the proposed quantitative shape features have additional prognostic value compared with standard clinical features, we controlled for tumor volume, patient age, and Karnofsky Performance Score (KPS). The FLAIR-based bounding ellipsoid volume ratio (BEVR), a 3D complexity measure, was strongly prognostic of survival, with a hazard ratio of 0.36 (95% CI 0.20-0.65), and remained significant in regression analysis after controlling for other clinical factors (P = 0.0061). Three enhancing-tumor based shape features were prognostic of survival independently of clinical factors: BEVR (P = 0.0008), margin fluctuation (P = 0.0013), and angular standard deviation (P = 0.0078). Algorithmically assessed tumor shape is statistically significantly prognostic of survival for patients with GBM independently of patient age, KPS, and tumor volume. This shows promise for extending the utility of MR imaging in treatment of GBM patients.

Entities:  

Keywords:  Glioblastoma; Magnetic resonance imaging; Prognosis; Shape; Survival

Mesh:

Year:  2017        PMID: 28074320     DOI: 10.1007/s11060-016-2359-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  35 in total

1.  Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

Authors:  M A Hammoud; R Sawaya; W Shi; P F Thall; N E Leeds
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Isolation and characterization of human malignant glioma cells from histologically normal brain.

Authors:  D L Silbergeld; M R Chicoine
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

3.  Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.

Authors:  Luke Macyszyn; Hamed Akbari; Jared M Pisapia; Xiao Da; Mark Attiah; Vadim Pigrish; Yingtao Bi; Sharmistha Pal; Ramana V Davuluri; Laura Roccograndi; Nadia Dahmane; Maria Martinez-Lage; George Biros; Ronald L Wolf; Michel Bilello; Donald M O'Rourke; Christos Davatzikos
Journal:  Neuro Oncol       Date:  2015-07-16       Impact factor: 12.300

4.  Quantitative classification of breast tumors in digitized mammograms.

Authors:  S Pohlman; K A Powell; N A Obuchowski; W A Chilcote; S Grundfest-Broniatowski
Journal:  Med Phys       Date:  1996-08       Impact factor: 4.071

5.  Analysis of the mortality probability of preoperative MRI features in malignant astrocytomas.

Authors:  Mehmet Ali Ekici; Turgay Bulut; Bulent Tucer; Ali Kurtsoy
Journal:  Turk Neurosurg       Date:  2011       Impact factor: 1.003

6.  Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.

Authors:  James S Cordova; Eduard Schreibmann; Costas G Hadjipanayis; Ying Guo; Hui-Kuo G Shu; Hyunsuk Shim; Chad A Holder
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

7.  Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2.

Authors:  Marc R J Carlson; Whitney B Pope; Steve Horvath; Jerome G Braunstein; Phioanh Nghiemphu; Cho-Lea Tso; Ingo Mellinghoff; Albert Lai; Linda M Liau; Paul S Mischel; Jun Dong; Stanley F Nelson; Timothy F Cloughesy
Journal:  Clin Cancer Res       Date:  2007-05-01       Impact factor: 12.531

8.  Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Authors:  Haruka Itakura; Achal S Achrol; Lex A Mitchell; Joshua J Loya; Tiffany Liu; Erick M Westbroek; Abdullah H Feroze; Scott Rodriguez; Sebastian Echegaray; Tej D Azad; Kristen W Yeom; Sandy Napel; Daniel L Rubin; Steven D Chang; Griffith R Harsh; Olivier Gevaert
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

9.  MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set.

Authors:  David A Gutman; Lee A D Cooper; Scott N Hwang; Chad A Holder; Jingjing Gao; Tarun D Aurora; William D Dunn; Lisa Scarpace; Tom Mikkelsen; Rajan Jain; Max Wintermark; Manal Jilwan; Prashant Raghavan; Erich Huang; Robert J Clifford; Pattanasak Mongkolwat; Vladimir Kleper; John Freymann; Justin Kirby; Pascal O Zinn; Carlos S Moreno; Carl Jaffe; Rivka Colen; Daniel L Rubin; Joel Saltz; Adam Flanders; Daniel J Brat
Journal:  Radiology       Date:  2013-02-07       Impact factor: 11.105

10.  Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.

Authors:  Yi Cui; Khin Khin Tha; Shunsuke Terasaka; Shigeru Yamaguchi; Jeff Wang; Kohsuke Kudo; Lei Xing; Hiroki Shirato; Ruijiang Li
Journal:  Radiology       Date:  2015-09-04       Impact factor: 11.105

View more
  8 in total

1.  Radiogenomics of lower-grade glioma: algorithmically-assessed tumor shape is associated with tumor genomic subtypes and patient outcomes in a multi-institutional study with The Cancer Genome Atlas data.

Authors:  Maciej A Mazurowski; Kal Clark; Nicholas M Czarnek; Parisa Shamsesfandabadi; Katherine B Peters; Ashirbani Saha
Journal:  J Neurooncol       Date:  2017-05-03       Impact factor: 4.130

2.  Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation.

Authors:  Satoka Shidoh; Ricky R Savjani; Nicholas S Cho; Henrik E Ullman; Akifumi Hagiwara; Catalina Raymond; Albert Lai; Phionah L Nghiemphu; Linda M Liau; Whitney B Pope; Timothy F Cloughesy; Tania B Kaprealian; Noriko Salamon; Benjamin M Ellingson
Journal:  J Neurooncol       Date:  2022-09-02       Impact factor: 4.506

3.  Effects of MRI scanner parameters on breast cancer radiomics.

Authors:  Ashirbani Saha; Xiaozhi Yu; Dushyant Sahoo; Maciej A Mazurowski
Journal:  Expert Syst Appl       Date:  2017-06-20       Impact factor: 6.954

Review 4.  Imaging in neuro-oncology.

Authors:  Hari Nandu; Patrick Y Wen; Raymond Y Huang
Journal:  Ther Adv Neurol Disord       Date:  2018-02-28       Impact factor: 6.570

5.  Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival.

Authors:  Yizhou Wan; Roushanak Rahmat; Stephen J Price
Journal:  Acta Neurochir (Wien)       Date:  2020-07-13       Impact factor: 2.216

6.  Introduction to radiomics and radiogenomics in neuro-oncology: implications and challenges.

Authors:  Niha Beig; Kaustav Bera; Pallavi Tiwari
Journal:  Neurooncol Adv       Date:  2021-01-23

Review 7.  Research Progress of Gliomas in Machine Learning.

Authors:  Yameng Wu; Yu Guo; Jun Ma; Yu Sa; Qifeng Li; Ning Zhang
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

8.  Localization patterns of cathepsins K and X and their predictive value in glioblastoma.

Authors:  Barbara Breznik; Clara Limback; Andrej Porcnik; Andrej Blejec; Miha Koprivnikar Krajnc; Roman Bosnjak; Janko Kos; Cornelis J F Van Noorden; Tamara T Lah
Journal:  Radiol Oncol       Date:  2018-10-18       Impact factor: 2.991

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.